BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17630727)

  • 1. Design, synthesis, and SAR study of a series of N-alkyl-N'-[2-(aryloxy)-5-nitrobenzenesulfonyl]ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor.
    Hanson J; Dogné JM; Ghiotto J; Moray AL; Kinsella BT; Pirotte B
    J Med Chem; 2007 Aug; 50(16):3928-36. PubMed ID: 17630727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptor.
    Hanson J; Reynaud D; Qiao N; Devel P; Moray AL; Renard JF; Kelley LP; Winum JY; Montero JL; Kinsella BT; Pirotte B; Pace-Asciak CR; Dogné JM
    J Med Chem; 2006 Jun; 49(12):3701-9. PubMed ID: 16759113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonists.
    Bambi-Nyanguile SM; Hanson J; Ooms A; Alpan L; Kolh P; Dogné JM; Pirotte B
    Eur J Med Chem; 2013 Jul; 65():32-40. PubMed ID: 23688698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
    J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
    Coyle AT; O'Keeffe MB; Kinsella BT
    FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of angio-associated migratory cell protein with the TPα and TPβ isoforms of the human thromboxane A₂ receptor.
    Reid HM; Wikström K; Kavanagh DJ; Mulvaney EP; Kinsella BT
    Cell Signal; 2011 Apr; 23(4):700-17. PubMed ID: 21172430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.
    Nakahata N
    Pharmacol Ther; 2008 Apr; 118(1):18-35. PubMed ID: 18374420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of lipid rafts in multiple signal transductions mediated by two isoforms of thromboxane A₂ receptor: dependency on receptor isoforms and downstream signaling types.
    Goto S; Saito M; Obara Y; Moriya T; Nakahata N
    Eur J Pharmacol; 2012 Oct; 693(1-3):15-24. PubMed ID: 22963705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the role of N-linked glycosylation on the cell signaling and expression of the human thromboxane A2 receptor alpha and beta isoforms.
    Walsh MT; Foley JF; Kinsella BT
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1026-36. PubMed ID: 9694965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.
    Mulvaney EP; Shilling C; Eivers SB; Perry AS; Bjartell A; Kay EW; Watson RW; Kinsella BT
    Oncotarget; 2016 Nov; 7(45):73171-73187. PubMed ID: 27689401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
    O'Sullivan AG; Mulvaney EP; Kinsella BT
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis.
    Laroche G; Lépine MC; Thériault C; Giguère P; Giguère V; Gallant MA; de Brum-Fernandes A; Parent JL
    Cell Signal; 2005 Nov; 17(11):1373-83. PubMed ID: 15893915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the TPα and TPβ isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TPβ during monocyte-macrophage differentiation.
    Mulvaney EP; O'Sullivan ÁG; Eivers SB; Reid HM; Kinsella BT
    Exp Mol Pathol; 2019 Oct; 110():104277. PubMed ID: 31271729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pathways for activation of extracellular signal-regulated kinase through thromboxane A2 receptor isoforms.
    Miyosawa K; Sasaki M; Ohkubo S; Nakahata N
    Biol Pharm Bull; 2006 Apr; 29(4):719-24. PubMed ID: 16595906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.
    Dogné JM; Hanson J; de Leval X; Kolh P; Tchana-Sato V; de Leval L; Rolin S; Ghuysen A; Segers P; Lambermont B; Masereel B; Pirotte B
    J Pharmacol Exp Ther; 2004 May; 309(2):498-505. PubMed ID: 14742735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.
    Turner EC; Kavanagh DJ; Mulvaney EP; McLean C; Wikström K; Reid HM; Kinsella BT
    J Biol Chem; 2011 Apr; 286(17):15440-57. PubMed ID: 21357687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylation of the TPbeta isoform of the human thromboxane A2 receptor. Modulation of G protein: effector coupling and modes of receptor internalization.
    Reid HM; Kinsella BT
    Cell Signal; 2007 May; 19(5):1056-70. PubMed ID: 17229546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms.
    Miggin SM; Kinsella BT
    Biochim Biophys Acta; 1998 Nov; 1425(3):543-59. PubMed ID: 9838218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.